Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ruslana Kotsofruk"'
Autor:
Yuval Shaked, Marcelle Machluf, Tomer Bronshtein, Ziv Raviv, Chen Rachman-Tzemah, Ofrat Beyar-Katz, Madeleine Benguigui, Ruslana Kotsofruk, Nitzan Letko-Khait, Michael Timaner
Supplemental Figures S1-7 supporting figures 1-6. Figure S1: Tumor growth in mice co�implanted with gemcitabine�educated MSCs and PANC1 cells. Figure S2: Viability and survival of TICs and MSCs in response to chemotherapy. Figure S3: TI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8e12cf52774fb364cf33eef0014f1f4
https://doi.org/10.1158/0008-5472.22411733.v1
https://doi.org/10.1158/0008-5472.22411733.v1
Autor:
Yuval Shaked, Marcelle Machluf, Tomer Bronshtein, Ziv Raviv, Chen Rachman-Tzemah, Ofrat Beyar-Katz, Madeleine Benguigui, Ruslana Kotsofruk, Nitzan Letko-Khait, Michael Timaner
Detailed description of several methods mentioned in the manuscript
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cdcd363434e9993cab0cbe9dc264b34
https://doi.org/10.1158/0008-5472.22411727
https://doi.org/10.1158/0008-5472.22411727
Supplemental Table S1 from Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells
Autor:
Yuval Shaked, Marcelle Machluf, Tomer Bronshtein, Ziv Raviv, Chen Rachman-Tzemah, Ofrat Beyar-Katz, Madeleine Benguigui, Ruslana Kotsofruk, Nitzan Letko-Khait, Michael Timaner
Fold change in the expression levels of factors secreted by gemcitabine-educated versus untreated MSCs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57e4994c2b9d9a353a19cdd0f903603a
https://doi.org/10.1158/0008-5472.22411730.v1
https://doi.org/10.1158/0008-5472.22411730.v1
Autor:
Yuval Shaked, Marcelle Machluf, Tomer Bronshtein, Ziv Raviv, Chen Rachman-Tzemah, Ofrat Beyar-Katz, Madeleine Benguigui, Ruslana Kotsofruk, Nitzan Letko-Khait, Michael Timaner
Stromal cells residing in the tumor microenvironment contribute to the development of therapy resistance. Here we show that chemotherapy-educated mesenchymal stem cells (MSC) promote therapy resistance via cross-talk with tumor-initiating cells (TIC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::670fd931202bb35c96bfaf804f641239
https://doi.org/10.1158/0008-5472.c.6508283.v1
https://doi.org/10.1158/0008-5472.c.6508283.v1
Autor:
Ruslana Kotsofruk, Elisabeth G.E. de Vries, Tongwu Zhang, Yuval Shaked, Orit Kaidar-Person, Michael Timaner, Tal Kan, Shahar Daniel, Robert S. Kerbel, Ziv Raviv, A. Nevelsky, Dvir Shechter, Ksenia Magidey
Publikováno v:
Oncogene
ONCOGENE, 39(1), 187-203. Nature Publishing Group
ONCOGENE, 39(1), 187-203. Nature Publishing Group
Radiotherapy induces immune-related responses in cancer patients by various mechanisms. Here, we investigate the immunomodulatory role of tumor-derived microparticles (TMPs)—extracellular vesicles shed from tumor cells—following radiotherapy. We
Autor:
Ruslana Kotsofruk, Ziv Raviv, Michael Timaner, Marcelle Machluf, Yuval Shaked, Ofrat Beyar-Katz, Chen Rachman-Tzemah, Nitzan Letko-Khait, Tomer Bronshtein, Madeleine Benguigui
Publikováno v:
Cancer Research
Stromal cells residing in the tumor microenvironment contribute to the development of therapy resistance. Here we show that chemotherapy-educated mesenchymal stem cells (MSC) promote therapy resistance via cross-talk with tumor-initiating cells (TIC)
Autor:
Ziv Raviv, Michael Timaner, Yuval Shaked, Susan A. Rotenberg, Dror Alishekevitz, Ruslana Kotsofruk, Rotem Bril, A. Nevelsky, Orit Kaidar-Person, Shahar Daniel, Chen Rachman-Tzemah, Valeria Miller
Publikováno v:
Oncotarget
// Michael Timaner 1, * , Rotem Bril 1, * , Orit Kaidar-Person 2 , Chen Rachman-Tzemah 1 , Dror Alishekevitz 1 , Ruslana Kotsofruk 1 , Valeria Miller 1 , Alexander Nevelsky 2 , Shahar Daniel 2 , Ziv Raviv 1 , Susan A. Rotenberg 3 , Yuval Shaked 1 1 D